RxDoctor Payments Data

Robert Snowden, MD

Otolaryngology · Jacksonville, FLNPI 1376545152

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,338 of the $1,719 with a category attached, or 77.8%. It is spread thinly across 16 manufacturers, the largest accounting for just 22.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $734, 9.1 times the $81 reported in 2019. That places this record below the midpoint for otolaryngology clinicians in FL, where the typical reported total is $1,552.

$1,719in general payments, 2019–2025

Across 55 payments — averaging $31.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$386
  • Sanofi$355
  • Regeneron Healthcare Solutions, Inc.$233
  • GSK$214
  • Aerin Medical Inc.$207
  • Optinose US, Inc.$106
  • plus $219 from 10 others

What the payments were for

  • Travel & lodging$28617%
  • Food & beverage$1,33878%
  • Education$925%
  • Gifts$40%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,719 in reported general payments places this provider in the 50th percentile of 586 otolaryngology providers in Florida.

See all otolaryngology providers in Florida →

Medicare billing

Part B allowed, 2024
$252,101
Medicare patients
365
Services billed
1,335

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide183$7,559
Fluticasone Propionate188$3,869
Famotidine166$3,076
Pantoprazole Sodium96$1,341
Omeprazole76$1,308
Montelukast Sodium88$1,164
Esomeprazole Magnesium13$537
Doxycycline Hyclate49$475
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen47$201
CefuroximeCefuroxime Axetil18$187
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav20$133
Cephalexin23$82
Prednisone17$50

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Jacksonville

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →